Patient experience and clinical evidence answer different questions
Medical cannabis is available on the NHS for a small number of conditions, and through private clinics for a wider range of cases where other treatments have not worked, caused side effects, or been unsuitable. The information can be confusing. You might read conflicting claims online, or hear about products that sound promising but are not backed by clear evidence or legal routes.
MCPH is patient-led, not a clinic or pharmacy. Patient experience can show which questions people need answered, but personal stories are not medical evidence and cannot promise access, symptom relief or a particular product outcome.
How to read patient experience alongside clinical advice
Patient experience can make a topic practical, for example when preparing for an appointment or keeping useful records. It does not show that the same approach will work for you; only your prescriber can assess your case.
A reported benefit from a strain or dose is not a recommendation or a promised outcome. Use reported experiences as prompts for questions, then discuss the relevant facts with your prescriber.
Sources behind the practical guidance
The guidance draws on the following sources:
- NHS medical cannabis guidance – which sets out the limited NHS indications and the general principles for prescribing.
- NICE guideline NG144 – which covers the evidence base for cannabis-based medicinal products.
- GMC guidance for doctors – which explains the professional responsibilities of clinicians who prescribe CBPMs.
- CQC expectations – which outline the standards that clinics and pharmacies must meet.
These sources make uncertainty explicit. A product is not described as working for anxiety, and a condition does not mean that a prescription will follow. Some patients may report using a product for anxiety, but the evidence can be limited and the prescriber still needs to assess whether it is appropriate.
The guidance does not use recreational, wellness or sales framing. Product lists, affiliate links and “buy now” buttons do not answer a clinical question.
Questions for an informed treatment discussion
If you are considering medical cannabis, or already have a prescription, here are some questions you might want to ask your clinician or pharmacist. These are starting points, not a checklist.
- What is the evidence base for the product you are recommending for my condition?
- How will we know if the treatment is working, and what will we do if it does not?
- What side effects should I watch for, and how do I report them?
- How do I manage my prescription safely, including storage and disposal?
- What should I do if I need to travel with my medication?
- Can you explain how the dosing schedule works, and what to do if I miss a dose?
Take questions about your treatment plan, product, route or timing to your prescribing clinician.
What a clinician needs to assess
Only a qualified clinician can assess your medical history, current treatments and whether a cannabis-based product might be suitable.
Clinic, product and pharmacy availability can change. Access depends on individual clinical assessment, local availability and the clinic’s policies.
If you are unsure where to start, the patient guide covers practical steps from first appointment to ongoing care.
Read next
- Patient guide: from first appointment to ongoing care
- Glossary of medical cannabis terms
- How to read an MCPH strain page
Sources
- NHS medical cannabis overview – https://www.nhs.uk/medicines/medical-cannabis/
- NICE guideline NG144 – https://www.nice.org.uk/guidance/ng144
- NHS England long read on CBPMs – https://www.england.nhs.uk/long-read/cannabis-based-products-for-medicinal-use-cbpms/
- GMC information for doctors on CBPMs – https://www.gmc-uk.org/professional-standards/learning-materials/information-for-doctors-on-cannabis-based-products-for-medicinal-use
- CQC guidance on cannabis-based medicinal products – https://www.cqc.org.uk/guidance-providers/healthcare/cannabis-based-medicinal-products-what-cqc-expects-providers
